|
1) Pozzi C, Bolasco PG, Foogazzi GB, et al. Corticosteroids in IgA nephropathy: A randomized controlled trial. Lancet. 1999; 353: 883-7
|
|
|
|
2) Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of randomized, controlled trial. J Am Soc Nephrol. 2004; 15: 157-63
|
|
|
|
|
|
3) Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidey Dis. 2001; 38: 736-43
|
|
|
|
|
|
4) Hotta O. Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy. Semin Nephrol. 2004; 24: 244-55
|
|
|
|
|
|
5) Xie Y, Nishi S, Ueno M, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003; 63: 1861-7
|
|
|
|
|
|
6) Komatsu H, Fujimoto S, Hara S, et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol. 2008; 3: 1301-7
|
|
|
|
|
|
7) Miura N, Imai H, Kikuchi S, et al. Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol. 2009; 13: 460-6
|
|
|
|
|
8) Locatelli F, Vecchio LD, Pozzi C, et al. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors. Nat Clin Pract Neurol. 2006; 2: 24-31
|
|
|
|
|
|
9) Appel GB, Waldman M. The IgA nephropathy treatment dilemma. Kidney Int. 2006; 69: 1939-44
|
|
|
|
|